JPMorgan Chase increases its stake in ALI HEALTH (00241) by approximately 172 million shares at a price of HK$6.069 per share.
After the increase, the latest number of shares held is about 1.688 billion, and the latest shareholding ratio is 10.43%.
The latest data from the Hong Kong Stock Exchange shows that on November 26, JPMorgan Chase increased its holdings of ALI HEALTH (00241) by approximately 171,589,632 shares, at a price of 6.069 Hong Kong dollars per share, with a total amount of approximately 1.041 billion Hong Kong dollars. After the increase, the latest number of shares held is approximately 1.688 billion shares, with a latest holding percentage of 10.43%.
Related Articles

Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.

Hunan Silver (002716.SZ) director Rongqi resigns
Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.

Hunan Silver (002716.SZ) director Rongqi resigns

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


